Viewing Study NCT03389256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-02 @ 6:10 PM
Study NCT ID: NCT03389256
Status: UNKNOWN
Last Update Posted: 2018-01-03
First Post: 2017-12-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Diseases View
None Neoplasms View
None Respiratory Tract Diseases View
None Thoracic Neoplasms View
None Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None apatinib View
None T790 negative View
None NSCLC View